Cargando…
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial
To compare FDG-PET/unenhanced MRI and FDG-PET/diagnostic CT in detecting infiltration in patients with newly diagnosed Hodgkin lymphoma (HL). The endpoint was equivalence between PET/MRI and PET/CT in correctly defining the revised Ann Arbor staging system. Seventy consecutive patients with classica...
Autores principales: | Picardi, M., Cavaliere, C., Della Pepa, R., Nicolai, E., Soricelli, A., Giordano, C., Pugliese, N., Rascato, M.G., Cappuccio, I., Campagna, G., Cerchione, C., Vigliar, E., Troncone, G., Mascolo, M., Franzese, M., Castaldo, R., Salvatore, M., Pane, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116299/ https://www.ncbi.nlm.nih.gov/pubmed/33909101 http://dx.doi.org/10.1007/s00277-021-04537-5 |
Ejemplares similares
-
[(18)F]FDG uptake of the normal spinal cord in PET/MR imaging: comparison with PET/CT imaging
por: Aiello, Marco, et al.
Publicado: (2020) -
Sulfur Exafluoride Contrast-Enhanced Ultrasound Showing Early Wash-Out of Marked Degree Identifies Lymphoma Invasion of Spleen with Excellent Diagnostic Accuracy: A Monocentric Study of 260 Splenic Nodules
por: Picardi, Marco, et al.
Publicado: (2022) -
Liposomal doxorubicin supercharge‐containing front‐line treatment in patients with advanced‐stage diffuse large B‐cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single‐centre phase II study
por: Picardi, Marco, et al.
Publicado: (2022) -
Rituximab-Containing Risk-Adapted Treatment Strategy in Nodular Lymphocyte Predominant Hodgkin Lymphoma: 7-Years Follow-Up
por: Pugliese, Novella, et al.
Publicado: (2021) -
Reply to the letter to the editor “chronic disseminated candidiasis” by Kenneth Rolston
por: Della Pepa, Roberta, et al.
Publicado: (2017)